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A B S T R A C T
A third collaborative exercise on RNA/DNA co-analysis for body ﬂuid identiﬁcation and STR proﬁling was
organized by the European DNA Proﬁling Group (EDNAP). Twenty saliva and semen stains, four dilution
series (10–0.01 ml saliva, 5–0.01 ml semen) and, optionally, bona ﬁde or mock casework samples of human or
non-human origin were analyzed by 20 participating laboratories using an RNA extraction or RNA/DNA co-
extraction method. Two novel mRNA multiplexes were used: a saliva triplex (HTN3, STATH and MUC7) and a
semen pentaplex (PRM1, PRM2, PSA, SEMG1 and TGM4). The laboratories used different chemistries and
instrumentationandamajority(16/20)wereabletosuccessfullyisolate anddetectmRNAindriedstains.The
simultaneous extraction of RNA and DNA from individual stains not only permitted a conﬁrmation of the
presence of saliva/semen (i.e. tissue/ﬂuid source of origin), but allowed an STR proﬁle of the stain donor to be
obtainedaswell. Themethodprovedtobereproducibleandsensitive,with aslittleas0.05 ml salivaor semen,
using different analysis strategies. Additionally, we demonstrated the ability to positively identify the
presence of saliva and semen, as well as obtain high quality DNA proﬁles, from old and compromised
casework samples. The results of this collaborative exercise involving an RNA/DNA co-extraction strategy
support the potential use of an mRNA based system for the identiﬁcation of saliva and semen in forensic
casework that is compatible with current DNA analysis methodologies.
 2012 Elsevier Ireland Ltd. All rights reserved.
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The analysis of cell-speciﬁc mRNA expression is a conﬁrmative
method for the identiﬁcation of body ﬂuids [1–24], as opposed to
conventional immunological and enzymatic tests, most of which
either lack speciﬁcity or cannot be used to identify all forensically
relevant biological ﬂuids. The suitability of mRNA proﬁling assays
with forensic samples, such as old and environmentally compro-
mised samples, has been demonstrated [25–28]. Previously, two
collaborative exercises were performed by the European DNA
Proﬁling Group (EDNAP – http://www.isfg.org/EDNAP) in order to
evaluate the robustness and reproducibility of mRNA proﬁling for
blood identiﬁcation: (1) evaluation of three blood-speciﬁc markers
(HBB, SPTB and PBGD) using singleplex reactions [29]; (2)
evaluation of seven blood-speciﬁc markers using two multiplex
systems, a ‘high sensitivity’ duplex (HBB, HBA) and a ‘moderate
sensitivity’ pentaplex (ALAS2, CD3G, ANK1, PBGD and SPTB) [30].
Most laboratories, some of which had no prior experience with
RNA, were able to successfully isolate and analyze RNA from the
provided samples. While sensitivity varied between laboratories,
the method proved to be reproducible and sensitive using different
analysis strategies [29,30].
A third collaborative exercise was organized by the Institute of
Legal Medicine, University of Zu¨rich, Switzerland, on behalf of
EDNAP in order to test forensically suitable saliva and semen
markers. In a preliminary study performed by the Florida and
Zu¨rich laboratories, various saliva and semen mRNA markers
described in the literature [3,6,8,9,13,15,18] as well as from
unpublished data (Table 1) were evaluated in terms of sensitivity,
speciﬁcity and performance with casework samples. In this study,
7 saliva and 11 semen markers were tested, of which 3 saliva and 5
semen markers were deemed most suitable for forensic use (Table
1). For this exercise, the following saliva and semen multiplexes
were developed and provided to the participating laboratories: (1)
a saliva triplex including the markers HTN3, STATH and MUC7 and
(2) a semen pentaplex allowing the detection and differentiation of
sperm (PRM1, PRM2) and seminal plasma (PSA, SEMG1 and TGM4),
the latter of which is necessary for the identiﬁcation of semen from
azoospermic men. The exercise included two rounds of testing: In
the original exercise (part 1), 5 laboratories encountered technicalTable 1
List of evaluated mRNA markers for the identiﬁcation of saliva and semen.
RNA marker Protein Ref.
Saliva
HTN3 Histatin 3 6
STATH Statherin 6
MUC7 Mucin 7 *
PRB1-3 Proline-rich proteins *
PRB4 Proline-rich protein 8
SPRR2A small proline -rich protein 2A 13
KRT13 Keratin 13 13
Semen
PRM1 Protamine 1 3,6
PRM2 Protamine 2 3,6
TGM4  Transglutaminase 4 18,*
PSA/KLK3 Prostate Specific Antigen, Kallikrein 3 9,15
SEMG1 Semenogelin 1 9,15
SPANXB SPANX family member B *
HSFY Heat Shock Transcription Factor, Y -Linked *
SPAM1-v2 Sperm Adhesion Molecule *
ZPBP Zona Pellucida Binding Protein *
ODF1 Outer Dense Fiber of Sperm Tails 1 *
BPY2/VCY2 Basic Charged, Y -linked, 2 *
* Ballantyne (unpublished)problems (reduced sensitivity, no result at all, contamination of
negative controls and spectral pull-ups). As a consequence, a
second exercise (part 2) was arranged in order identify the source
of these problems, and potentially to obtain improved results. Each
part of the exercise included the analysis of 10 mock casework
samples, saliva and semen dilution series and, if available, optional
extra casework samples from the participating laboratories. In
addition to the provided samples analyzed by all laboratories, a set
of human tissues and animal saliva samples were tested with the
multiplexes by 4 laboratories to complement the speciﬁcity testing
of the markers.
2. Materials and methods
2.1. Samples and materials provided
The organizing laboratory (Institute of Legal Medicine, Univer-
sity of Zu¨rich, Switzerland) sent 2 sets of samples to the
participating laboratories: part 1 included stains 1–10 (saliva,
semen, non-saliva/semen and non-human stains) and dilution
series A (5–0.01 ml semen) and B (5–0.01 ml saliva); part 2
included stains 11–20 (saliva, semen, non-saliva/semen and non-
human stains) and dilution series C (10–0.05 ml saliva) and D (5–
0.01 ml semen). Fresh saliva samples were collected from 10
individuals for 12 stains/dilution series (different donors were
used for parts 1 and 2 except for one donor who was used in both
parts) and were deposited onto different carrier materials
including cotton swab/pads, recycling tissue, paper and glass
slides. Additionally, quarter pieces of chewed chewing gums and
licked plastic spoons were provided. Semen samples from 9
individuals were used to prepare 10 stains/dilution series
(different donors were used for parts 1 and 2 except for one
donor who was used in both parts). The semen, which had been
frozen for up to 25 years, was deposited onto different carrier
materials including cotton swab/pads, white textile, toilet paper
and latex gloves. In addition, blood samples (2 donors), vaginal
swabs (1 donor) and buccal swabs from a dog and a cat were used
as non-saliva/semen and non-human stains. For the dilution series,
saliva and semen samples were diluted in 0.9% NaCl to a ﬁnal
volume of 5 ml per sample and placed on swabs. The laboratoriesgood candidates
not sensitive
not specific
good candidates
inconstistent results during 
singleplex testing
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bona ﬁde or mock casework material that could include human
and/or non-human saliva and semen stains; or (2) other
forensically relevant body ﬂuids (semen, saliva, vaginal secretions
or menstrual blood).
HPLC-puriﬁed primers were purchased from Microsynth (St.
Gallen, Switzerland) or Applied Biosystems (AB, Rotkreuz,
Switzerland). The organizing laboratory prepared primer mixes
for the multiplexes and aliquots were provided to the participating
laboratories for use in ampliﬁcation reactions (see below). In the
second part, singleplex primers for HTN3, MUC7, PRM2 and SEMG1
were provided to permit a comparison of results obtained using
singleplex and multiplex analysis. The primers and samples were
sent by normal post (part 1, arrival within 2–4 days, except 2
parcels that were 7 and 11 days in transit) or by Fedex (part 2,
arrival within 1–3 days, except 1 parcel that was 7 days in transit).
2.2. Human tissue and animal samples
Total RNA from 20 human tissues (adipose, bladder, brain,
cervix, colon, esophagus, heart, kidney, liver, lung, ovary, placenta,
prostate, skeletal muscle, small intestine, spleen, testes, thymus,
thyroid and trachea) included in the FirstChoice1 Human Total
RNA Survey Panel was obtained from Applied Biosystems/Ambion.
All tissues included in the panel were 3-donor pooled samples.
Buccal swabs and semen samples of domestic and exotic
animals were collected by veterinary practitioners, zookeepers, a
volunteer at an animal shelter, and/or owners (laboratories 9, 10
and 19). Although some samples were obtained from the same
species, they were collected from different animals.
2.3. RNA(/DNA co-)extraction and reverse transcription
The participating laboratories were asked to use the entire swab
or stain for extraction (RNA only or RNA/DNA co-extraction). The
organizing laboratory provided an example protocol for extraction
and reverse transcription. The laboratories could, however, use
methods of their own choice. The example protocol was described
previously [29,30].
2.4. RNA- and DNA-quantiﬁcation
Participating laboratories were asked to quantify RNA using one
of the following methods: Quant-iTTM RiboGreen1 RNA Assay kit
(Invitrogen) using a ﬂuorescence microplate reader (high and low
range protocol option) [6]; Quant-iTTM RNA assay kit (Invitrogen)
using the Qubit ﬂuorometer [21]; or Bioanalyzer (Agilent) [15].
Laboratories were able to quantify DNA using a quantiﬁcation
system of their own choice (Table S1, supplementary materials).
2.5. Endpoint PCR
The primer sets and amplicon lengths are shown in Table S2. An
additional larger amplicon (152 bp) detected in saliva samples
using the HTN3 primers corresponds to another histatin isoform
(HTN1), which shows 95% sequence identity to HTN3 [6,14]. For
the animal sample testing, it was expected that many ‘‘negative’’
results would be obtained due to the deliberate design and use of
putative human or primate speciﬁc primer sequences. In an
attempt to ensure that a negative result was genuine and not due
to an absence of high quality RNA in the extract itself, all animal
samples were tested using a housekeeping gene (HKG) triplex
(B2M, UBC and UCE).
In the ﬁrst part of the exercise, the forward primers were 50-
labeled with the alternative dyes Yakima Yellow or ATTO550 (VIC1
and NEDTM analogs, respectively). The alternative dyes causedspectral issues such as pull-up in the other dyes due to the use of
matrices generated with the commonly used dyes VIC1 and NEDTM
(AB). This is not a problem as long as all markers in the multiplex
are labeled with one dye. For the second part of the exercise, the
forward primers were labeled with the commonly used dyes
(semen: VIC, saliva: NED) so that the correct spectral calibration
matrices could be applied. The HKG forward primers were 50-
labeled with ATTO550.
The following ampliﬁcation conditions were recommended:
saliva and HKG triplex: the 25 ml reaction mix contained 2 ml cDNA,
2.5 ml primer mix (see below), 12.5 ml 2 Multiplex PCR
Mastermix (Multiplex PCR kit, QIAGEN), 2.5 ml Q-Solution (Multi-
plex PCR kit; QIAGEN); semen pentaplex: the 25 ml reaction mix
contained 2 ml cDNA, 2.5 ml primer mix (see below), 1 mM dNTPs
(AB), 1 Buffer II (AB), 3.25 mM MgCl2 (AB), and 1.5 U AmpliTaq1
Gold DNA Polymerase (AB); saliva and semen singleplexes: the 25 ml
reaction mix contained 2 ml cDNA, 2 ml primer mix (see below),
0.5 mM dNTPs (AB), 1 Buffer I (AB) and 1.25 U AmpliTaq Gold1
DNA Polymerase (AB). Sterile water was used in place of cDNA for
non-template controls.
The primer mixes were prepared using the following concen-
trations: saliva triplex: HTN3 0.2 mM, STATH 0.4 mM, MUC7
0.1 mM; semen pentaplex: PSA 0.72 mM, PRM2 0.048 mM, SEMG1
0.2 mM, TGM4 0.6 mM, PRM1 0.12 mM; saliva and semen single-
plexes: 0.8 mM each; HKG triplex: B2M 0.2 mM, UBC 0.2 mM, UCE
1 mM.
The cycling conditions were as follows: saliva triplex: the initial
denaturation was at 95 8C for 15 min, followed by 35 cycles of 94 8C
30 s, 57 8C (+0.2 8C per cycle) 90 s, 72 8C 60 s and the ﬁnal
elongation at 72 8C for 60 min; semen pentaplex and saliva/semen
singleplexes: the initial denaturation was at 95 8C for 11 min,
followed by 35 cycles of 94 8C 20 s, 58 8C 30 s, 72 8C 40 s and the
ﬁnal elongation at 72 8C for 60 min; HKG triplex: the initial
denaturation was at 95 8C for 15 min, followed by 35 cycles of 94 8C
30 s, 55 8C (+0.2 8C per cycle) 90 s, 72 8C 40 s and the ﬁnal
elongation at 72 8C for 30 min.
Post PCR puriﬁcation was recommended, particularly for the
semen pentaplex, to eliminate dye blobs that could appear at
marker speciﬁc positions (e.g. MinElute PCR puriﬁcation kit,
QIAGEN) [21,31].
2.6. Capillary electrophoresis (CE)
The participating laboratories used standard, multi-color
ﬂuorescent genetic analyzers and standard electrophoresis con-
ditions for the detection of the saliva and semen speciﬁc amplicons
(Table S1). Any dye set that included VIC1 and NEDTM, with
associated internal lane standard, could be used. Raw data were
analyzed with Genemapper1 Software (AB). For data compilation,
the threshold for a positive result was set to 100 RFUs (relative
ﬂuorescence units) for consistency between laboratories and to
avoid inclusion of false positive results (due to the presence of dye
blobs, baseline noise).
2.7. DNA-ampliﬁcation and -detection
If DNA was co-extracted, the laboratories were able to use a
standard STR typing kit, PCR and CE conditions of their choice
(Table S1). A peak detection threshold of 50 RFUs was used.
3. Results
Laboratories 1–18 participated in part 1 of the exercise (stains
1–10 and dilution series A and B) and laboratories 1, 3–6, 8–13, 15–
20 participated in part 2 (stains 11–20 and dilution series C and D).
Each laboratory was asked to complete a questionnaire describing
C. Haas et al. / Forensic Science International: Genetics 7 (2013) 230–239 233the methods used (Table S1). The 20 laboratories used 5 different
kits for RNA only or RNA/DNA co-extraction, 7 different reverse
transcription kits, 7 different STR typing kits for DNA analysis, 5
different thermocyclers, 4 different genetic analyzers and 3
different polymers (Table S1).
The exercise was performed in 2 parts to allow for laboratories
that encountered technical problems in part 1 to test additional
samples once technical issues had been resolved (see Introduc-
tion). Laboratories that did not encounter technical challenges in
part 1 were still encouraged to participate in part 2 of the exercise
for comparison of the results from part 1 and for further evaluation
of the included markers. From the experiences of part 1, various
improvements were applied to part 2: (1) primers were labeled
with common dyes to prevent pull-up into other spectra; (2) four
RNA markers were provided additionally as singleplexes to permit
comparisons of singleplex and multiplex analyses. Improved
results could not be obtained in part 2 by laboratories 3, 4 and
6. These laboratories encountered non-identiﬁed technical pro-
blems, which were not attributable to the mRNA proﬁling method.
Therefore, the results from these laboratories were excluded fromTable 2
mRNA proﬁling results (saliva triplex and semen pentaplex) from 13 laboratories for the
than half of the laboratories, light gray squares are stains/markers that were detected by
detected by less than 25% of the laboratories. The number of laboratories that typed at lea
eSxelpirtavilaS.oNelpmaS
HTN3 STATH MUC 7 P 
31/1131/431/73eussitgnilcycernoavilaslu3
31/931/631/66muggniwehcdewehc4/1
31/2131/2131/218bawslaccub4/1
31/2131/0131/1101dapnoavilaslu5
31/331/431/311repapnoavilaslu5
31/631/431/941edilsssalgnoavilaslu5
2 ul saliva on swab / 1 ul blood 18 10/13 9/1 3 11/13
31/731/531/991noopscitsalpdekcil
5 ul saliva / 1 ul semen mix on swab 5 13/13 13/13 13/13 6 
 5 ul saliva  / 1 ul semen mix on  swab 16 12/13 12/13 13/13 8 
2 ul semen on swab 1 1/13 8 
39elitxetetihwnonemeslu3
451repapteliotnonemeslu2
102evolgxetaledisninemeslu3
5 ul azoospermic semen on swab 4 1/13 1 
121dapnonemescimrepsoozalu3 
3 ul human blood on swab 2 
31/431/131bawslanigav1/4  
1/4 buccal swab (dog) 7 1/13 
31/171)tac(bawslaccub4/1 
Table 3
mRNA proﬁling results (saliva triplex and semen pentaplex) from 13 laboratories for the
squares represent stains/markers that were detected by more than half of the laborat
laboratories and white squares represent stains/markers that were detected by less th
saliva dilution series B saliva dilution series C se men dilut
HTN3 STATH MUC7 HTN3 STATH MUC7 PS A PRM
10 ul n.d. n.d. n.d. 13/13 13/13 13/13 n.d. n.d 
5 ul 12/13 11/13 12/13 13/13 13/13 13/13 11/13 12/1
1 ul 11/13 10/13 10/13 12/13 7/13 12/13 8/13 11/1
0.5 ul 10/13 5/13 10/13 9/13 6/13 11/13 6/13 10/1
0.1 ul 4/13 5/13 1/13 2/13 4/13 3/13 6/1
0.05 ul 2/13 1/13 4/13 1/13 5/13 6/1
0.01 ul 1/13 n.d. n.d. n.d. 2/13 3/1
n.d., not determined.the ﬁnal data compilation. The data of laboratories 5 and 18 (part 1)
and laboratory 19 (part 2) were excluded from the RNA results due
to the use of a non-functional reverse transcriptase (lab 5) and the
presence of RT minus contamination (labs 18 and 19). With the
above mentioned laboratories excluded from data compilation,
there was no signiﬁcant difference in the results between parts 1
and 2 in terms of detectability and sensitivity of RNA markers and
recoverability of STR proﬁles. Therefore, the results of parts 1 and 2
were combined in the tables and ﬁgures presented here.
3.1. RNA results
The mRNA proﬁling results are summarized in Tables 2 and 3.
For exercise parts 1 and 2, thirteen laboratories (although not the
same 13 laboratories in each part) were able to perform the
method successfully as demonstrated by detection of the RNA
saliva and semen markers. The 8 saliva and 6 semen stains were
identiﬁed correctly by most laboratories (Table 2). Analysis of stain
11 (5 ml saliva on paper) appeared to be challenging possibly due to
the presence of inhibiting substances in the paper. Stains 4 and 12 20 stains. Dark gray squares represent stains/markers that were detected by more
 25–50% of the laboratories and white squares represent stains/markers that were
st two markers of the respective body ﬂuid correctly is shown in the last 2 columns.
evitisopsrekram2>xelpatnepnem
SA PRM2 SEMG1  TGM 4 PRM 1 Saliv a Semen
31/8
31/7
31/21
31/21
31/3
31/6
1/13 11/13
31/7
/13 13/1 3 13/1 3 10/1 3 13/1 3 13/1 3 13/13
/13 10/1 3 12/1 3 6/1 3 10/1 3 13/1 3 12/13
/13 13/1 3 13/1 3 10/1 3 13/1 3 13/13
31/1131/931/431/0131/0131/
31/931/931/431/831/931/
31/0131/1131/331/631/931/
0/13 3/13 12/13 11/13 1/13 12/13
31/0 2/13 11/13 11/1 3 11/13
13/13 13/13
31/1 8/13 12/13
12/13 13/13
31/1 12/13 12/13
 2 saliva and 2 semen dilution series (A, B from part 1; C, D from part 2). Dark gray
ories, light gray squares are stains/markers that were detected by 25–50% of the
an 25% of the laboratories.
ion series A se men dilution series  D
2 SEMG1 TGM4 PRM1 PS A PRM2 SEMG1  TGM4 PRM1
. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
3 12/13 10/13 12/13 12/13 13/13 13/13 13/13 13/13
3 12/13 6/13 12/13 12/13 13/13 12/13 12/13 13/13
3 11/13 3/13 10/13 8/13 11/13 11/13 12/13 11/13
3 8/13 1/13 7/13 1/13 5/13 2/13 1/13 8/13
3 2/13 3/13 3/13 1/13 6/13 3/13 2/13 7/13
3 2/13 4/13 1/13
C. Haas et al. / Forensic Science International: Genetics 7 (2013) 230–239234were semen samples from azoospermic men and, therefore, no
detection of PRM1 and PRM2 was expected. However, up to 3
laboratories detected one of these markers, which may be due to
detection of residual sperm despite vasectomy. Two stains
were saliva/semen mixtures (stains 5 and 16), both of which
were identiﬁed as mixtures by all laboratories (Table 2). FourFig. 1. Representative electropherograms of saliva (a) and semen (b) stains, a saliva dil
analyzed with the saliva triplex and the semen pentaplex. The saliva stains were 5 ml sa
semen on a swab (#16), licked plastic spoon (#19); the semen stains were 3 ml azoosperm
1 ml semen on a swab (#16), 3 ml semen inside latex glove (#20) (results from laboratory
Some samples were saturated resulting in split peaks (s) and typical overﬂow peaks (*non-saliva/non-semen/non-human samples were included, and
most laboratories (Table 2) obtained the expected result, which
was the lack of any mRNA signal from the putative semen and
saliva markers. However, sporadic single marker signals of
unknown origin were obtained from the multiplex analysis by
a small number of laboratories, mainly from the vaginal swabution series (c: 5, 0.05 ml saliva) and a semen dilution series (d: 5, 0.01 ml semen)
liva on paper (#11), 5 ml saliva on glass slide (#14), mixture of 5 ml saliva and 1 ml
ic semen on a pad (#12), 2 ml semen on toilet paper (#15), mixture of 5 ml saliva and
 12). The dilution series results were post PCR puriﬁed (results from laboratory 11).
, dimmed) around 10 bp in front of the main peaks [21].
C. Haas et al. / Forensic Science International: Genetics 7 (2013) 230–239 235(Table 2). Representative electropherograms of saliva and semen
stains are shown in Fig. 1a and b. HTN3, STATH and MUC7 were
detected down to 0.5 ml saliva by more than half of the
laboratories. A small number of laboratories were able to detect
the saliva markers in as little as 0.05 ml saliva (Table 3 and Fig. 1c).
The semen markers PSA, PRM2, SEMG1, TGM4 and PRM1 were
detectable down to 0.5 ml semen by more than half of the
laboratories. A small number of laboratories detected the semen
markers in as little as 0.01 ml semen (Table 3 and Fig. 1d). In part 2,
some markers were also tested as singleplexes on the stains and
the dilution series. Since the differences between multiplex and
singleplex testing were marginal, singleplex results are not shown
nor discussed further.
No expression was detected for any of the markers in the RT
minus (no reverse transcriptase added) or PCR negative controls by
a majority of the laboratories. Laboratories 18 (only in part 1, not in
part 2) and 19 (participated only in part 2) observed expression in
RT minus controls and were therefore not included in data
compilation.
Only four laboratories quantiﬁed the RNA in part 1: two used
the Quant-iTTM RNA assay kit, one used the Quant-iTTM Ribo-
Green1 RNA Assay kit and one used the Bioanalyzer. Overall, the
RNA quantiﬁcation results were highly variable, probably because
of the small stain sizes and the different quantiﬁcation methods.
Therefore, we did not attempt to determine the correlation (if any)
between the quantiﬁcation result and the RNA proﬁling success.
Post-PCR puriﬁcation resulted in increased peak heights and
reduced baseline signal noise but did not allow for detection of
additional markers that were not observed prior to post-PCR
puriﬁcation. Post-PCR puriﬁcation could be critical for the
interpretation of the semen pentaplex results with dye blobs at
marker-speciﬁc positions. Fifteen laboratories in part 1 and 11
laboratories in part 2 performed post-PCR puriﬁcation.
3.2. DNA results
Fourteen and eleven laboratories (parts 1 and 2, respectively)
performed RNA/DNA co-extraction. No speciﬁcation of DNA
analysis was provided. Various STR typing kits and cycle numbers
were utilized by the participating laboratories (Table S1). Thus, as aTable 4
DNA proﬁling results from 14 laboratories (part 1) and 11 laboratories (part 2) for 2 sal
various STR typing kits. Only the 10 SGM Plus loci were taken into account. Dark gray sq
light gray squares are stains/loci that were detected by 25–50% of the laboratories an
laboratories.
saliva dilution series B
vWA D16 D2 AML D8 D21 D18 D19 TH01 FGA D3 
10 ul n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
5 ul 13/14 12/14 12/14 13/14 13/14 13/14 12/14 13/14 13/14 13/14 13/14
1 ul 10/14 7/14 6/14 11/14 9/14 9/14 6/14 9/14 11/14 7/14 8/14
0.5 ul 8/14 6/14 2/14 10/14 6/14 5/14 5/14 9/14 10/14 5/14 6/14
0.1 ul 1/14 2/14 1/14 2/14 1/14 2/14
0.05 ul 1/14 1/14 2/14 1/14 1/14 1/14
0.01 ul 1/14
semen dilution series A
vWA D16 D2 AML D8 D21 D18 D19 TH01 FGA D3 
5 ul 14/14 14/14 14/14 14/14 14/14 14/14 13/14 14/14 14/14 13/14 14/14
1 ul 14/14 12/14 13/14 13/14 14/14 12/14 12/14 12/14 12/14 12/14 12/14
0.5 ul 14/14 13/14 13/14 14/14 14/14 13/14 13/14 13/14 13/14 13/14 13/14
0.1 ul 12/14 11/14 11/14 11/14 11/14 12/14 10/14 12/14 12/14 12/14 12/14
0.05 ul 12/14 8/14 8/14 11/14 10/14 8/14 7/14 9/14 10/14 9/14 8/14
0.01 ul 9/14 5/14 8/14 8/14 8/14 7/14 7/14 6/14 8/14 7/14 8/14
n.d., not determined.result of the varying conditions used, direct sensitivity and success
rate comparisons could not be made. However, the results
demonstrated that DNA of sufﬁcient quantity and quality for
STR analysis can be simultaneously extracted with RNA from small
amounts of dried saliva and semen (Table 4). Full STR proﬁles were
obtained from all human donor stains by most laboratories (data
not shown). The obtained genotypes were conﬁrmed by compari-
son with the reference proﬁles. Full proﬁles were obtained from
the saliva dilution series C from 0.5 ml saliva stains, whereas partial
proﬁles were obtained down to 0.1 ml saliva (Table 4). The quality
of the STR typing results of saliva dilution series B was slightly
lower, possibly resulting from donor-speciﬁc differences. From the
semen dilution series A and D, full STR proﬁles were obtained from
as little as 0.05 ml semen stains, and partial STR proﬁles were
obtained from 0.01 ml semen (Table 4).
3.3. RNA and DNA results of the optional stain samples
The laboratories were invited to analyze additional samples
including bona ﬁde and mock casework samples, non-saliva, non-
semen and non-human body ﬂuid samples. Eighteen saliva stains
and 18 semen stains were analyzed by 7 different laboratories. At
least one of the speciﬁc markers was detectable in almost all saliva
and semen stains, including various sizes, storage periods and
storage conditions (Table 5). Representative RNA and DNA
electropherograms are shown in Figs. S1 and S2. With saliva
stains, only an outdoor saliva sample (covered, 7d) showed no
result at all, probably due to degradation or absence of genetic
material from exposure to outdoor conditions. Two of the semen
stains were negative, probably because of low input amount,
difﬁcult starting material or questionable semen contribution.
Twenty-one non-saliva samples (4 blood, 6 semen, 8 vaginal
swabs and 3 others) were analyzed with the saliva triplex by 8
laboratories. Five ‘cross reactive’ peaks (all <1000 RFUs) were
observed, again mainly in vaginal swabs (Table 5). Twenty-one
non-semen samples (4 blood, 8 saliva, 7 vaginal swabs and 2
others) were analyzed with the semen pentaplex by 8 laboratories.
Only 1 ‘cross reactive’ peak was observed (SEMG1 in a blood sample).
Full autosomal STR proﬁles were obtained for most samples where
an RNA/DNA co-extraction was performed (data not shown).iva and 2 semen dilution series (A, B from part 1; C, D from part 2) ampliﬁed with
uares represent stains/loci that were detected by more than half of the laboratories,
d white squares represent stains/loci that were detected by less than 25% of the
saliva dilution series C
vWA D16 D2 AML D8 D21 D18 D19 TH01 FGA D3
11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11
11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11
10/11 9/11 8/11 10/11 10/11 9/11 10/11 9/11 9/11 9/11 10/11
9/11 9/11 8/11 10/11 10/11 9/11 9/11 9/11 10/11 9/11 9/11
3/11 2/11 1/11 5/11 3/11 1/11 2/11 2/11 2/11 1/11 5/11
2/11 1/11
n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
semen dilution series D
vWA D16 D2 AML D8 D21 D18 D19 TH01 FGA D3
11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11
11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11
11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11 11/11
9/11 6/11 4/11 9/11 10/11 9/11 7/11 9/11 5/11 7/11 7/11
8/11 4/11 3/11 6/11 8/11 6/11 5/11 5/11 4/11 5/11 3/11
3/11 2/11 1/11 1/11
Table 5
mRNA proﬁling results of the optional stains that were analyzed by the participating laboratories (casework or mock samples, non-saliva/non-semen samples, old stains and
environmentally exposed stains). Numbers are peak heights in RFUs, light gray squares represent RNA peaks <1000 RFUs, dark gray squares >1000 RFUs.
additional saliva stains or non-saliva samples additional semen stains or non-semen samples
3NTHselpmas avilasbal STATH 2MRP ASPselpmas nemesbal7CUM SEMG1 TGM4 PRM1
5 wet swab of coffee mug (area of mouth contact) 8280 0 0 5 0.9cm2 area  from panties, sexual assault (PSA pos.) 1835 889 9 661 0 0 8231
5 wet swab of water bottle (area of mouth contact) 00842200repap no mreps79807387
5 wet swab of mouth speaker office phone 006400mreps tsorfed7071110
7 defrost sperm + saliva 9566 9469 9985 7 defrost sperm + saliva 0 0 20 0 0 0
29087762974312229310713 namuh morf nemes9122990392039E avilas7
0753325970195800823 namuh morf nemes9835957697669A avilas7
14977841308164848012035 namuh morf nemes9003949496559N avilas7
63283865394738589864yad 1 ,derevoc edistuo ,nemes11652962696169S avilas7
syad 7 ,derevoc edistuo ,nemes118299240802lμ 1 E avilas7 0 0 0 0 0
12876847105873879887shtnom 3 rof C°73 ta derots nemes11962757240179lμ 5 E avilas7
98289006662857389854htnom 1 rof C°65 ta derots nemes11227916240167lμ 01 E avilas7
11 saliva, outside covered, 1 da y 8644 9349 307 2 11 semen on denim, stored at RT for 6 months 0 848 3 741 2 545 4 8502
11 saliva, outside covered, 7 day s 0 0 0 13 mixed stain on fabric, stored at RT for 4 years 9791 3219 9 2090 2 2451 4 31647
11 saliva, stored at 37°C for 3 month s 933 6 67 5 896 5 16 1 μl prostate secretio n 680 9 0 136 9 730 7 0
11 saliva, stored at 56°C for 1 mont h 906 4 9458 8732 16 vaginal swab + sperm (1 μl) 0 0 0 0 0
11 saliva on denim, stored at RT for 6 months 0 0 5255 16 sperm in condom (1 μl 1:10 dil. ) 165 5 788 5 813 2 361 6 7577
16 cigarette butt (only filter, 2 mm wide)  116 9 25 8 0 17 mixed stain ( menstrual blood, semen) on swab 551 743 7 653 2 105 1 7377
17 mixed stain (menstrual blood, saliva) on swab 6214 327 3 9540 17 5 μl azoospermic semen stain,  2 years old 166 0 0 661 7 133 7 0
lab non-saliva sample s HTN3 STATH MUC7 la b non-semen sample s PSA PRM2 SEMG1 TGM4 PRM1
0018700ATF no doolb lμ 32000ATF no doolb lμ 32
11 50 μl blood on cotton 0 0 0 11 50 μl blood on cotton 0 0 0 0 0
13 10 μl blood on swab, stored at RT for 1 year 0 0 0 13 10 μl blood on swab, stored at RT for 1 year 0 0 0 0 0
doolb41000doolb41 0 0 0 0 0
5 0.9cm2 area  from panties, sexual assault (PSA pos.) 0 0 0 5 wet swab of coffee mug (area of mouth contact) 0 0 0 0 0
5000repap no mreps7 wet swab of water bottle (area of mouth contact) 0 0 0 0 0
5000mreps tsorfed7 wet swab of mouth speaker office phone 0 0 0 0 0
16 sperm in condom (1 μl 1:10 dil. ) 0 0 0 7 saliva E 0 0 0 0 0
16 1 μl prostate secretio n 0 0 29 2 7 saliva A 0 0 0 0 0
17 5 μl azoospermic semen stain,  2 years old 0 0 0 7 saliva N 0 0 0 0 0
S avilas7000baws lanigav 2/111 0 0 0 0 0
 )ediw mm 2 ,retlif ylno( ttub etteragic61000baws lanigav61 0 0 0 0 0
16 vaginal swab + Sperm (1 μl ) 0 0 0 11 1/2 vaginal swab 0 0 0 0 0
17 vaginal swab TSI 4 day s 22 1 0 0 16 vaginal swab 0 0 0 0 0
17 vaginal swab TSI  ≥7 day s 0 0 0 17 vaginal swab TSI 4 days 0 0 0 0 0
17 vaginal swab TSI  ≥7 day s 0 0 0 17 vaginal swab TSI  ≥7 days 0 0 0 0 0
17 vaginal swab TSI 2 day s 0 0 55 0 17 vaginal swab TSI  ≥7 days 0 0 0 0 0
17 vaginal swab TSI 2 day s 0 0 27 2 17 vaginal swab TSI 2 days 0 0 0 0 0
11 1/2 menstrual swa b 0 0 0 17 vaginal swab TSI 2 days 0 0 0 0 0
13 mixed stain on fabric, stored at RT for 4 years 0 0 0 11 1/2 menstrual swab 0 0 0 0 0
17 mixed stain ( menstrual blood, semen) on swab 0 62 4 0 17 mixed stain (menstrual blood, saliva) on swab 0 0 0 0 0
C. Haas et al. / Forensic Science International: Genetics 7 (2013) 230–2392363.4. Tissue- and species-speciﬁcity of the saliva and semen multiplexes
The organizing laboratory (Zu¨rich) tested the saliva and semen
multiplexes on total RNA from a commercially available human
tissue panel, including 20 human tissues (Table S3). The saliva
triplex only showed positive signals with thyroid and trachea. The
semen pentaplex showed reactions only with prostate and testes
(Table S3).
Three laboratories (Brussels, Glasgow, Copenhagen) tested the
saliva and semen multiplexes on animal saliva and semen samples.
The only animal samples where species cross-reactivity was
observed were gorilla saliva (HTN3, STATH and MUC7 (Table 6))
and chimpanzee semen (TGM4 (Table 7)). Most animal samples
showed positive reactions with at least one of the housekeeping
genes, conﬁrming the presence of RNA in these samples.
4. Discussion
The purpose of this exercise was to evaluate an RNA/DNA co-
extraction strategy with challenging saliva and semen samples and
two novel saliva- and semen-speciﬁc mRNA multiplexes (a saliva
triplex with the saliva-speciﬁc markers HTN3, STATH and MUC7 as
well as a semen pentaplex with the semen-speciﬁc markers PSA,
PRM2, SEMG1, TGM4 and PRM1). The semen pentaplex permits the
detection of both, sperm and seminal plasma, thereby allowing theidentiﬁcation of both spermic and azoospermic semen. Co-extracted
DNA was analyzed with various commercial STR typing kits.
Most participating laboratories successfully applied the method
using their own laboratory equipment and different kits and
chemicals for RNA only or RNA/DNA co-extraction, reverse
transcription and PCR. The samples to be analyzed in this exercise
were challenging because the laboratories did not know the tissue
origin and all stains were low template samples. The differing
sensitivities between the laboratories can be explained by the
different extraction kits and reverse transcription biochemicals
and the skill sets within the laboratories, since those laboratories
with more experience in RNA analysis in general produced better
results than the others. The data from a small number of
laboratories was excluded due to technical problems not
attributable to the mRNA proﬁling method.
The evaluated saliva and semen markers proved to be speciﬁc
and sensitive and therefore suitable for forensic stains, even aged
and low template samples. ‘‘Speciﬁcity’’ in the context of gene
expression and in reference to a speciﬁc body ﬂuid can indicate
either that expression of a particular gene is only observed in the
body ﬂuid of interest or can be used to describe markers whose
expression is signiﬁcantly higher in the body ﬂuid of interest than in
other body ﬂuids. While the latter is perhaps more frequently
observed and presents a greater challenge in terms of interpretation,
proper interpretation guidelines could be developed to still permit
Table 6
Saliva triplex results of animal saliva samples. In addition, the expression of 3
housekeeping genes (B2M, UBC, UCE) was analyzed to conﬁrm successful analysis
despite negative saliva results. Numbers are peak heights in RFUs, positive results
(>100 RFUs) are highlighted by shading.
lab Animal HTN3 STATH MUC7 B2 M UB C UCE 
10 Bearded dragon 0 0 0 0 0 0
10 Bull 0 0 0 0 0 0
10 Ca t 0 0 0 0 0 1851
9 Ca t 0 0 0 n.d. n.d. n.d.
10 Chicken 0 0 0 0 0 0
10 Chinese water dragon 0 0 0 0 0 522
9 Co w 0 0 0 n.d. n.d. n.d.
10 Degu 0 0 0 0 0 2014
10 Do g 0 0 0 0 0 0
9 Do g 0 0 0 n.d. n.d . n.d.
10 Duck 0 0 0 0 0 378
10 Gerbil 0 0 0 0 0 0
10 Goat 0 0 0 0 0 404
10 Gorill a 9259 8890 45 4 948 1 36 6 651
10 Guinea pig 0 0 0 0 0 0
10 Horse 0 0 0 0 0 0
9 Hors e 0 0 0 n.d. n.d. n.d.
10 Jackdaw 0 0 0 0 0 1061
10 Leguan 0 0 0 0 0 498
10 Miniature horse 0 0 0 63 64 1 0
10 Pi g 0 0 0 0 0 4052
10 Pigeon 0 0 0 0 0 7733
10 Rabbit 0 0 0 0 0 0
10 Huma n 7878 6405 7748 933 1 400 2 156
n.d., not determined.
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ﬂuid. The purpose of this study was not to develop such guidelines
(hopefully it will be the subject of future EDNAP studies once
markers for all relevant body ﬂuids have been evaluated), but to
simply begin to critically evaluate the sensitivity and speciﬁcity of
reported semen- and saliva-speciﬁc markers and to initially
demonstrate their potential future implementation in forensic
casework.Table 7
Semen pentaplex results of animal semen samples. In addition, the expression of 3
housekeeping genes (B2M, UBC, UCE) was analyzed to conﬁrm successful analysis
despite negative semen results. Numbers are peak heights in RFUs, positive results
(>100 RFUs) are highlighted by shading, asterisks indicate saturation.
lab Animal PS A PRM2 SEM G1 TGM4 PRM1 B2M UBC UCE
9 Chimpanzee 0 0 0 252 7 0 n.d . n.d . n.d .
19 Cow 0 0 0 0 0 0 0 0
19 Deer 0 0 0 0 0 0 0 118 7
9 Dog 0 0 0 0 0 n.d . n.d . n.d .
19 Dog  1 0 0 0 0 0 0 0 415 1
19 Dog  2 0 0 0 0 0 0 0 0
19 Dog  3 0 0 0 0 0 54 1 0 335 5
19 Goat 1 0 0 0 0 0 162 7 0 0
19 Goat 2 0 0 0 0 0 337 4 265 0 0
19 Ho rse 1 0 0 0 0 0 0 0 105 5
19 Ho rse 2 0 0 0 0 0 0 0 94 6
19 Ho rse 3 0 0 0 0 0 10 ,492* 514 9 253 5
9 Pig 0 0 0 0 0 n.d . n.d . n.d .
19 Pig 1 0 0 0 0 0 0 0 0
19 Pig 2 0 0 0 0 0 10 6 0 0
19 Pig 3 0 0 0 0 0 0 0 0
19 Sheep 1 0 0 0 0 0 0 0 0
19 Sheep 2 0 0 0 0 0 0 0 0
19 Hu man 8945 * 8556 * 9330 * 9119 * 8851 * 10 ,331* 10 ,164* 10 ,470*
n.d., not determined.With the examined saliva and semen markers, single cross-
reactive peaks were observed in non-target body ﬂuids. Most of
them appeared only once and may be characterized as outliers. The
only reproducible ﬁnding of putative cross reactivity was a MUC7
transcript in some vaginal samples. Mucins are high molecular
weight glycosylated proteins that form a major part of a protective
bioﬁlm on the surface of epithelial cells, where they can provide a
barrier to particulate matter and bind microorganisms. MUC4 was
originally described as vaginal marker, but has been found to cross-
react with saliva [16,24]. Therefore, some cross-reactivity of MUC7
in vaginal samples is not surprising, particularly because vaginal
swabs normally contain large quantities of epithelial cells.
Additionally, in this study many laboratories did not perform an
RNA quantiﬁcation prior to reverse transcription resulting in the
input of likely increased amounts of RNA. Since some markers will
have lower level expression in non-target body ﬂuids, it is critical
that suitable input RNA levels are utilized in order to reduce the
occurrence of such cross reactivity. The use of RNA quantiﬁcation
prior to the reverse transcription reaction would allow for a
standardization of the input of RNA into the reaction thus possible
resulting in a reduction in the occurrence of such cross reactivity.
However, it may be premature at this stage to make a deﬁnitive
determination of whether MUC7 will have a role in the identiﬁcation
of saliva. It may be possible, for example, to use MUC7 in
combination with other markers in order to develop an expression
proﬁle for saliva.
The multiplex PCR systems need some further optimization prior
to routine use in casework analysis because of multiplex design
issues (e.g. split peaks, noisy baseline). However, the multiplexes
used in these initial studies were simply designed to permit more
efﬁcient analysis compared to singleplex reactions (reducing time
and cost for participating laboratories) and therefore did not
undergo a full developmental validation before their use in the
study. As a result, some of these design issues are expected. The use
of post-PCR puriﬁcation improved the quality of the multiplex
results (reduced appearance of split peaks, dye blobs, etc.) and
increased peak heights from low level samples. Therefore, it is
possible that post-PCR puriﬁcation could be included as part of the
standard protocol in order to resolve quality issues without
requiring signiﬁcant labor-intensive multiplex optimization experi-
ments.
RNA quantiﬁcation was performed by 4 laboratories, but the
results were not consistent, probably because of the low template
samples and/or insufﬁcient sensitivity of the quantiﬁcation
methods. None of the suggested RNA quantiﬁcation systems are
ideal as they are not human-speciﬁc. The Bioanalyzer normally
attests poor RNA quality and low RNA Integrity Numbers (RIN) with
forensic samples [15]. One of the 4 laboratories used an RNA-carrier
before RNA quantiﬁcation which could have interfered with the
results.
The saliva and semen multiplexes conﬁrmed body ﬂuid- and
species-speciﬁcity when tested on human tissues and animal
samples. Positive reactions of the saliva triplex with thyroid and
trachea and the semen pentaplex with prostate and testes is not
surprising, since these tissues are associated with the respective
body ﬂuids. Both multiplexes showed positive reactions with
primate samples. Cross-reactivity with primate samples is not
entirely unexpected due to the close evolutionary relatedness to
humans, but the presence of primate biological material is not
likely to be found in forensic cases.
HKG expression could not be shown for all animal samples to
conﬁrm successful analysis despite a negative body ﬂuid result.
The 3 housekeeping gene markers were designed for human use,
but the sequences are very similar in mammals. Failure to detect
HKG expression could therefore result from species speciﬁcity of
the HKG primers, low input amount or the lack of suitable quality
C. Haas et al. / Forensic Science International: Genetics 7 (2013) 230–239238RNA. The results are consistent with the saliva and semen markers
having a high degree of speciﬁcity for humans/primates.
The following negative controls were included in RNA analysis:
(1) RT minus (no reverse transcriptase added) to identify possibly
contaminating DNA (frequently a larger size than the expected
RNA product) or the presence of pseudogenes (same size as RNA
product); (2) ampliﬁcation blank. Laboratories 18 and 19 encoun-
tered problems with negative controls and therefore their results
were not used in this study. In the evaluated multiplexes, RT minus
controls should be negative because of prudent primer-design and
no known pseudogenes. Contamination could happen during PCR
(e.g. contamination of the mastermix with template) or during CE
(e.g. re-using sample septa or buffer septa, crosstalk or carryover
[32]).
The possibility of co-extracting RNA and DNA from the same
stain sample is an important advantage since the amount of
sample is often limited in forensic casework. The quantity and
quality of DNA from co-extracted samples seemed to be sufﬁcient
for both casework and environmentally exposed samples. From
almost all stains, good quality DNA proﬁles and the positive
identiﬁcation of saliva and semen could be achieved; even stains
exposed to un-controlled humidity and old stains could be
identiﬁed correctly. The use of RNA/DNA co-extraction methods
presents an interesting opportunity to evaluate possible quantita-
tive relationships between DNA and RNA from the same sample.
However, such an evaluation could not be performed in the present
study since there was variation in the chemistries, instruments and
protocols that were used by the various laboratories, particularly
for DNA where any STR kit could be used (i.e. no standard
conditions between laboratories). Additionally, many laboratories
did not perform RNA quantiﬁcation and the current RNA
quantiﬁcation systems that are available may be inﬂuenced by
contaminating residual DNA or endogenous bacteria present in
some ﬂuids. Therefore, this study, as was originally intended,
simply afﬁrms that a co-extraction strategy can be successfully
utilized to obtain RNA and STR proﬁling results from individual
samples. Future evaluation and validation of such an approach
could indeed determine if quantitative relationships between DNA
and RNA can be made in order to assist in interpretation of results.
In summary, the results of this study support an RNA/DNA co-
extraction strategy allowing for positive identiﬁcation of the
tissue/ﬂuid source of origin (saliva and semen) by mRNA proﬁling
as well as a simultaneous identiﬁcation of the body ﬂuid donor by
STR proﬁling. The evaluated 3 saliva and 5 semen markers proved
to be robust, reproducible and sensitive. Co-extracted DNA from
the same stain provided good-quality STR proﬁles. For future body
ﬂuid identiﬁcation systems, multiplexes for the simultaneous
identiﬁcation of several body ﬂuids and possibly tissues would be
preferable. A subsequent EDNAP mRNA exercise will include an
evaluation of mRNA markers for the identiﬁcation of menstrual
blood and housekeeping genes. The collective knowledge gained
from this series of collaborative exercises is likely to facilitate the
formulation of recommended practices and procedures for mRNA
proﬁling for body ﬂuid identiﬁcation. A major task will be the
interpretation of RNA results, especially of partial and mixed RNA
proﬁles. This will be the subject of future EDNAP exercises, once all
markers and possibly multiplexes have been evaluated.
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